H.S. Passed & Diploma in Nursing/pharmacy Other Preferred Qualification experience in the relevant field. A candidate in service of Government, a local or statutory body is required to submit no objection certificate from present employer. No Objection Certificate from present employer has to be furnished if selected for appointment.

Structural characterization, pharmacokinetics, pharmacodynamic and herb-drug interactions of major constituents of compound Unani formulation for diabetes. The candidate should have a Masters degree MS/ M.Pharm/ M.Sc. with age not exceeding more than 28 years on the last date of the application.

Assessing the theranostic capabilities of the Aurora-A/TPX2 Complex in Gallbladder Cancer; MSc/ MTech in Life Sciences, Biotechnology, Biochemistry, Microbiology, Toxicology, Molecular oncology, Bioinformatics, Molecular Oncology, and Genetics with two years of research experience in Biochemistry/Biotechnology/Immunology/Molecular Biology. The candidate should have a valid UGC-CSIR NET/ GATE/ GPAT/ DST/ DBT/ DAE/ DOS/ DRDO/ MHRD score.

research experience and knowledge in theoretical or computational biophysics, biophysical chemistry, protein dynamics, molecular dynamics simulations; Candidate should be familiar with enhanced sampling methods and MATLAB coding. Site-Specific Mechanism Of Aberrant Inter-Molecular Self-Assembly Of Full-Length TDP-43 In Neurodegeneration

M.Sc. in Biological Sciences Botany/ Biochemistry/ Biotechnology/ Environmental Science/ Microbiology/Plant Science from a recognized University or equivalent.

B.Pharm / M. Sc. Analytical Chemistry. Experience or Fresher Can also Apply; Preparation of Specifications in LIMS. Preparation of Methods in LIMS. Preparation of Standard Testing Procedures in LIMS.

Genome instability and inflammatory disorders; M.Sc. in Biotechnology, Biochemistry, Molecular Biology, Biomedical Sciences, M.Tech. in Biotechnology; Molecular biology, animal cell culture, and bioinformatics. Western blotting and immunofluorescence experiments. Applicants with a strong interest in inflammatory disorders or cancer biology and willing to work as part of a team are encouraged to apply for the post.

Downstream and Upstream Manufacturing Mammalian and Microbial, QMS; DP Medical Device, Packing and Visual Inspection Labelling, Cartoning, Pick and Place Robotic Machines Handling and Track and Trace; DP and DS Engineering, Maintenance Automation, Instrumentation, Injectable Maintenance, QMS; M.Pharm, B.Pharm, MSc Chemistry, Biotechnology, Life science, Microbiology

GLP, Raw Material -Packaging Material, In Process-Finished Product, Method Verification Protocol preparation & Document Section Knowledge required; Water sampling/testing, EM Observation, Culture Handling, Media Management, Having Digital exposure for LIMS/ MODA Software B.Sc/ M.Sc/ B.Pharm; Lead QC operations as Shift In-Charge. Review analytical data, Ensure compliance with LIMS, GLP, ALCOA ICH/FDA

Towards Discovery and Development of Novel Drugs and Pharmaceuticals. Experience in Natural Product Isolation and Characterization, Evident from Publication. Organic Synthesis, Natural Product Isolation, HPLC analysis.

ICMR funded extramural project titled Polymeric nanomedicine mediated inhalation therapy to treat chronic obstructive pulmonary disease (COPD) related inflammation; M.Sc. Biotechnology / Bioengineering / Biomedical Science; M.Tech. Biotechnology / Bioengineering / Biomedical Engineering; M.Pharm. Pharmaceutics / Pharmaceutical Technology

Required Trial Coordinator under Resonance Research Capacity Building; Post Graduation in Science M.Pharm, Life Sciences, Biotech, Zoology, Botany, etc. with PG Diploma in Clinical Research is mandatory. The Tata Memorial Centre, TMC is a Comprehensive Cancer Centre with a mission to achieve the highest standards in patient care, cancer prevention, cancer research and professional development for oncology and allied disciplines.

Synthesis and Evaluation of Nitrogen Tethered Derivatives in Cell-Based and Animal Models of Acute Lung Injury. The candidates should possess an M.Pharm/ M.S. Pharm./ M.Sc. in Chemical Science/ Medicinal Chemistry /Pharmaceutical Chemistry/ Pharmaceutical Sciences/ Chemistry/ Biochemistry or a PG degree in other relevant branch of Chemical Sciences.

diploma in pharmacy with experience in a hospital of repute. Must have registration with the state or Central Pharmacy Council; Institute of Liver and Biliary Sciences, ILBS is an autonomous super-specialty Institute of excellence under GNCT of Delhi and a Deemed-to-be-University by the UGC.

ICMR Extramural project titled Study on the Pharmacological Inhibition of Human Sperm GSK3a and Calcineurin on Fertilization Parameters to Develop Male Contraceptives at the Manipal Centre for Biotherapeutics Research. M.Sc. Biotechnology / Biochemistry / Microbiology / Molecular Biology/Genome Engineering/ Medical Biotechnology/ Biomedical Science / Life Science,  M.Tech. Biotechnology / Biomedical Engineering,  M.Pharm

Delineating and characterizing the m6A RNA methylation marks in primary and relapsed B-cell Acute Lymphoblastic Leukemia; MSc Life Sciences research experience or PhD in life sciences; Hands on research experience in molecular biology experiments PCR, Real Time PCR, Cloning, bioinformatics analysis of transcriptomes, exomes, custom analysis is desirable.

A multi-omics approach to delineate the role of neutrophil and plasma indicators in the progression of sepsis and predisposition to early mortality in Severe Alcoholic Hepatitis, SAH Patients. First class post graduate degree including integrated PG degrees

A post graduate degree in any discipline, preferably related to Medical or Allied and Healthcare education or healthcare policy or health administration or public health from any University with outstanding ability and proven administrative capacity and integrity.

A Randomized, Double-blind, Parallel Group, Multi-center, Phase III Study to Assess the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler Relative to Glycopyrronium and Formoterol Fumarate MDI on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease